Third-Line Therapy in Metastatic Colorectal Cancer
- PMID: 37437152
- DOI: 10.1056/NEJMc2306486
Third-Line Therapy in Metastatic Colorectal Cancer
Comment on
-
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963. N Engl J Med. 2023. PMID: 37133585 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical